Acadia Pharmaceuticals | Ativo Circulante

Preço das Ações
23.99
Mudança Diária
-0.34 -1.40%
Mensal
-10.35%
Anual
20.25%
Q1 Previsão
23.25




Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
ALKERMES USD 1.74B 106.38M 2025-09
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Corcept Therapeutics USD 541.13M 98.02M 2025-09
Cytokinetics USD 977.35M 90.81M 2025-09
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Incyte USD 5.02B 746.01M 2025-12
J&J USD 55.62B 1.01B 2025-12
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Prothena USD 339.97M 45.51M 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12


Acadia Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.